Related Experiment Videos
The opportunistic and bacterial infections associated with pediatric human immunodeficiency virus disease
1Department of Pediatrics, College of Physicians and Surgeons of Columbia University, New York City.
Insights
Despite advances in HIV care, opportunistic infections still threaten children. New strategies are improving outcomes, leading to longer, healthier lives for pediatric HIV patients.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- Opportunistic and bacterial infections are primary causes of mortality in Human Immunodeficiency Virus (HIV)-infected children.
- Recent advancements in early HIV diagnosis, antiretroviral therapies, infection treatment, and prevention strategies have been made.
- These advances are altering the natural progression of pediatric HIV infection, leading to improved survival rates.
Purpose of the Study:
- To review the epidemiology, predictors, and treatments of common infections in pediatric HIV disease.
- To highlight how current medical progress impacts the health outcomes of children with HIV.
Main Methods:
- Literature review of common infections in pediatric HIV.
- Analysis of epidemiological data, risk factors, and therapeutic interventions.
Main Results:
- Common infections reviewed include Pneumocystis carinii pneumonia, recurrent bacterial infections, candidiasis, herpes group viruses, mycobacterial disease, and cryptosporidiosis.
- Advances in HIV management are associated with improved life expectancy for infected children.
Conclusions:
- While significant challenges remain, current interventions are positively impacting the long-term prognosis for children with HIV.
- Continued research and implementation of effective treatment and prevention strategies are crucial for managing infections in this population.
Abstract:
Opportunistic and bacterial infections remain the leading causes of death of Human Immunodeficiency Virus-infected children, despite recent advances in the diagnosis of HIV infection during early infancy; antiretroviral therapies; advances in the treatment of some infections; an improved understanding of the cellular immune systems during early childhood; and new strategies for the prevention of some infections. However, these advances appear to be changing the natural history of pediatric HIV infection, resulting in an improved and longer life for infected children. This article briefly reviews the epidemiology, predictors, and treatments of the most common infections associated with pediatric HIV disease, including Pneumocystis carinii pneumonia, recurrent bacterial infections, candidiasis, herpes group viruses, mycobacterial disease and cryptosporidiosis.